Table 3.
Method | Feature type | Training set (n = 362) |
Test set (n = 155) |
|||
---|---|---|---|---|---|---|
AUC | C-index (SE) | AUC | C-index (SE) | p value | ||
GARSL | Preclinical | 0.863 | 0.790 (0.016) | 0.679 | 0.647 (0.034) | <0.001* |
GARSL | Radiomics | 0.740 | 0.518 (0.023) | 0.566 | 0.533 (0.035) | <0.001* |
GARSL | Preoperative | 0.781 | 0.738 (0.018) | 0.739 | 0.695 (0.032) | REF |
GARSL | Postoperative | 0.767 | 0.723 (0.019) | 0.741 | 0.710 (0.031) | <0.001* |
ERASL-pre | Preoperative | 0.667 | 0.659 (0.021) | 0.687 | 0.672 (0.017) | <0.001* |
ERASL-post | Postoperative | 0.672 | 0.656 (0.022) | 0.688 | 0.666 (0.018) | <0.001† |
C-index, concordance index; AUC, area under the receiver operating characteristic curve; SE, standard error; ERASL, early recurrence after surgery for liver tumor; GARSL, genetic algorithm for predicting recurrence after surgery of liver cancer.
p value compared to the GARSL preoperative score. † p value compared to the GARSL postoperative score.